Embark with us!

Tempest

Veterinary Report by Embark

embarkvet.com

Test Date: July 7th, 2017

Customer-supplied information

Owner Name: Annie St.Clair
Dog Name: Tempest
Sex: Female (intact)
Date of birth: 01/11/17

Breed type: purebred
Breed: Doberman Pinscher
Breed registration: American Kennel Club (AKC) WS55731609
Microchip: N/A

Genetic summary

Genetic breed identification:
Doberman Pinscher

Breed ancestry:

Doberman Pinscher: 100.0%

Predicted adult weight: 68 lbs

Calculated from 17 size genes.

Life stage: Mature adult

Based on date of birth provided.

Health Report

How to interpret Tempest’s genetic health results:

If Tempest inherited any of the variants that we tested, they will be listed at the top of the Health Report section, along with a description of how to interpret this result. We also include all of the variants that we tested Tempest for that we did not detect the risk variant for.

A genetic test is not a diagnosis

This genetic test does not diagnose a disease. Please talk to your vet about your dog’s genetic results, or if you think that your pet may have a health condition or disease.

Summary

Of the 164 genetic health risks we analyzed, we found 3 results that you should learn about.

Increased risk results

(2)

Dilated Cardiomyopathy, DCM1

Dilated Cardiomyopathy, DCM2

Notable results

(1)

ALT Activity

Clear results

Breed-relevant

(1)

Other

(160)

Health Report

Breed-relevant Results

Research studies indicate that these results are more relevant to dogs like Tempest, and may influence her chances of developing certain health conditions.

Dilated Cardiomyopathy, DCM1 (PDK4, Doberman Pinscher Variant 1)

Increased risk

Dilated Cardiomyopathy, DCM2 (TTN, Doberman Pinscher Variant 2)

Increased risk

Von Willebrand Disease Type I, Type I vWD (VWF)

Clear

Health Report

Other Results

Research has not yet linked these conditions to dogs with similar breeds to Tempest. Review any increased risk or notable results to understand her potential risk and recommendations.

ALT Activity (GPT)

Notable

2-DHA Kidney & Bladder Stones (APRT)

Clear

Acral Mutilation Syndrome (GDNF-AS, Spaniel and Pointer Variant)

Clear

Adult-Onset Neuronal Ceroid Lipofuscinosis, NCL A, NCL 12 (ATP13A2, Tibetan Terrier Variant)

Clear

Alaskan Husky Encephalopathy (SLC19A3)

Clear

Alaskan Malamute Polyneuropathy, AMPN (NDRG1 SNP)

Clear

Alexander Disease (GFAP)

Clear

Anhidrotic Ectodermal Dysplasia (EDA Intron 8)

Clear

Autosomal Dominant Progressive Retinal Atrophy (RHO)

Clear

Canine Elliptocytosis (SPTB Exon 30)

Clear

Canine Fucosidosis (FUCA1)

Clear

Canine Leukocyte Adhesion Deficiency Type III, CLAD III (FERMT3, German Shepherd Variant)

Clear

Canine Multifocal Retinopathy, cmr1 (BEST1 Exon 2)

Clear

Canine Multifocal Retinopathy, cmr2 (BEST1 Exon 5, Coton de Tulear Variant)

Clear

Canine Multifocal Retinopathy, cmr3 (BEST1 Exon 10 Deletion, Finnish and Swedish Lapphund, Lapponian Herder Variant)

Clear

Canine Multiple System Degeneration (SERAC1 Exon 4, Chinese Crested Variant)

Clear

Canine Multiple System Degeneration (SERAC1 Exon 15, Kerry Blue Terrier Variant)

Clear

Centronuclear Myopathy, CNM (PTPLA)

Clear

Health Report

Other Results

Cerebellar Hypoplasia (VLDLR, Eurasier Variant)

Clear

Chondrodystrophy (ITGA10, Norwegian Elkhound and Karelian Bear Dog Variant)

Clear

Cleft Lip and/or Cleft Palate (ADAMTS20, Nova Scotia Duck Tolling Retriever Variant)

Clear

Cobalamin Malabsorption (CUBN Exon 8, Beagle Variant)

Clear

Cobalamin Malabsorption (CUBN Exon 53, Border Collie Variant)

Clear

Collie Eye Anomaly (NHEJ1)

Clear

Complement 3 Deficiency, C3 Deficiency (C3)

Clear

Congenital Hypothyroidism (TPO, Tenterfield Terrier Variant)

Clear

Congenital Macrothrombocytopenia (TUBB1 Exon 1, Cairn and Norfolk Terrier Variant)

Clear

Congenital Myasthenic Syndrome, CMS (COLQ, Labrador Retriever Variant)

Clear

Congenital Myasthenic Syndrome, CMS (CHAT, Old Danish Pointing Dog Variant)

Clear

Congenital Stationary Night Blindness (RPE65, Briard Variant)

Clear

Craniomandibular Osteopathy, CMO (SLC37A2)

Clear

Cystinuria Type I-A (SLC3A1, Newfoundland Variant)

Clear

Cystinuria Type II-A (SLC3A1, Australian Cattle Dog Variant)

Clear

Cystinuria Type II-B (SLC7A9, Miniature Pinscher Variant)

Clear

Day Blindness (CNGA3 Exon 7, German Shepherd Variant)

Clear

Day Blindness (CNGA3 Exon 7, Labrador Retriever Variant)

Clear

Health Report

Other Results

Day Blindness (CNGB3 Exon 6, German Shorthaired Pointer Variant)

Clear

Degenerative Myelopathy, DM (SOD1A)

Clear

Dry Eye Curly Coat Syndrome (FAM83H Exon 5)

Clear

Dystrophic Epidermolysis Bullosa (COL7A1, Golden Retriever Variant)

Clear

Early Onset Cerebellar Ataxia (SEL1L, Finnish Hound Variant)

Clear

Enamel Hypoplasia (ENAM Deletion, Italian Greyhound Variant)

Clear

Episodic Falling Syndrome (BCAN)

Clear

Exercise-Induced Collapse, EIC (DNM1)

Clear

Factor VII Deficiency (F7 Exon 5)

Clear

Familial Nephropathy (COL4A4 Exon 3, Cocker Spaniel Variant)

Clear

Fetal-Onset Neonatal Neuroaxonal Dystrophy (MFN2, Giant Schnauzer Variant)

Clear

Glanzmann's Thrombasthenia Type I (ITGA2B Exon 13, Great Pyrenees Variant)

Clear

Glanzmann's Thrombasthenia Type I (ITGA2B Exon 12, Otterhound Variant)

Clear

Globoid Cell Leukodystrophy, Krabbe disease (GALC Exon 5, Terrier Variant)

Clear

Glycogen Storage Disease Type IA, Von Gierke Disease, GSD IA (G6PC, Maltese Variant)

Clear

Glycogen Storage Disease Type IIIA, GSD IIIA (AGL, Curly Coated Retriever Variant)

Clear

Glycogen storage disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM, Whippet and English Springer Spaniel Variant)

Clear

Glycogen storage disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM, Wachtelhund Variant)

Clear

Health Report

Other Results

GM1 Gangliosidosis (GLB1 Exon 2, Portuguese Water Dog Variant)

Clear

GM1 Gangliosidosis (GLB1 Exon 15, Shiba Inu Variant)

Clear

GM1 Gangliosidosis (GLB1 Exon 15, Alaskan Husky Variant)

Clear

GM2 Gangliosidosis (HEXA, Japanese Chin Variant)

Clear

GM2 Gangliosidosis (HEXB, Poodle Variant)

Clear

Golden Retriever Progressive Retinal Atrophy 1, GR-PRA1 (SLC4A3)

Clear

Golden Retriever Progressive Retinal Atrophy 2, GR-PRA2 (TTC8)

Clear

Hemophilia A (F8 Exon 11, German Shepherd Variant 1)

Clear

Hemophilia A (F8 Exon 1, German Shepherd Variant 2)

Clear

Hemophilia A (F8 Exon 10, Boxer Variant)

Clear

Hemophilia B (F9 Exon 7, Terrier Variant)

Clear

Hemophilia B (F9 Exon 7, Rhodesian Ridgeback Variant)

Clear

Hereditary Ataxia, Cerebellar Degeneration (RAB24, Old English Sheepdog and Gordon Setter Variant)

Clear

Hereditary Cataracts (HSF4 Exon 9, Boston Terrier Variant)

Clear

Hereditary Footpad Hyperkeratosis (FAM83G, Terrier and Kromfohrlander Variant)

Clear

Hereditary Nasal Parakeratosis, HNPK (SUV39H2)

Clear

Hereditary Vitamin D-Resistant Rickets (VDR)

Clear

Hypocatalasia, Acatalasemia (CAT)

Clear

Health Report

Other Results

Hypomyelination and Tremors (FNIP2, Weimaraner Variant)

Clear

Ichthyosis, Epidermolytic Hyperkeratosis (KRT10, Terrier Variant)

Clear

Ichthyosis, ICH1 (PNPLA1, Golden Retriever Variant)

Clear

Inherited Myopathy of Great Danes (BIN1)

Clear

Intervertebral Disc Disease (Type I) (FGF4 retrogene - CFA12)

Clear

Juvenile Epilepsy (LGI2)

Clear

L-2-Hydroxyglutaricaciduria, L2HGA (L2HGDH, Staffordshire Bull Terrier Variant)

Clear

Lagotto Storage Disease (ATG4D)

Clear

Late Onset Spinocerebellar Ataxia (CAPN1)

Clear

Ligneous Membranitis, LM (PLG)

Clear

Long QT Syndrome (KCNQ1)

Clear

Macular Corneal Dystrophy, MCD (CHST6)

Clear

Malignant Hyperthermia (RYR1)

Clear

May-Hegglin Anomaly (MYH9)

Clear

Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA (SGSH Exon 6, Dachshund Variant)

Clear

Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA (SGSH Exon 6, New Zealand Huntaway Variant)

Clear

Mucopolysaccharidosis Type VII, Sly Syndrome, MPS VII (GUSB Exon 3, German Shepherd Variant)

Clear

Mucopolysaccharidosis Type VII, Sly Syndrome, MPS VII (GUSB Exon 5, Terrier Brasileiro Variant)

Clear

Health Report

Other Results

Multiple Drug Sensitivity (ABCB1)

Clear

Muscular Dystrophy (DMD, Cavalier King Charles Spaniel Variant 1)

Clear

Muscular Dystrophy (DMD, Golden Retriever Variant)

Clear

Musladin-Lueke Syndrome, MLS (ADAMTSL2)

Clear

Myotonia Congenita (CLCN1 Exon 23, Australian Cattle Dog Variant)

Clear

Myotonia Congenita (CLCN1 Exon 7, Miniature Schnauzer Variant)

Clear

Narcolepsy (HCRTR2 Intron 6, Labrador Retriever Variant)

Clear

Neonatal Cerebellar Cortical Degeneration (SPTBN2, Beagle Variant)

Clear

Neonatal Encephalopathy with Seizures, NEWS (ATF2)

Clear

Neuronal Ceroid Lipofuscinosis 1, NCL 1 (PPT1 Exon 8, Dachshund Variant 1)

Clear

Neuronal Ceroid Lipofuscinosis 10, NCL 10 (CTSD Exon 5, American Bulldog Variant)

Clear

Neuronal Ceroid Lipofuscinosis 2, NCL 2 (TPP1 Exon 4, Dachshund Variant 2)

Clear

Neuronal Ceroid Lipofuscinosis 5, NCL 5 (CLN5 Exon 4 SNP, Border Collie Variant)

Clear

Neuronal Ceroid Lipofuscinosis 5, NCL 5 (CLN5 Exon 4 Deletion, Golden Retriever Variant)

Clear

Neuronal Ceroid Lipofuscinosis 6, NCL 6 (CLN6 Exon 7, Australian Shepherd Variant)

Clear

Neuronal Ceroid Lipofuscinosis 7, NCL 7 (MFSD8, Chihuahua and Chinese Crested Variant)

Clear

Neuronal Ceroid Lipofuscinosis 8, NCL 8 (CLN8, Australian Shepherd Variant)

Clear

Neuronal Ceroid Lipofuscinosis 8, NCL 8 (CLN8 Exon 2, English Setter Variant)

Clear

Health Report

Other Results

Neuronal Ceroid Lipofuscinosis, Cerebellar Ataxia, NCL4A (ARSG Exon 2, American Staffordshire Terrier Variant)

Clear

Osteochondrodysplasia (SLC13A1, Poodle Variant)

Clear

Osteogenesis Imperfecta (COL1A2, Beagle Variant)

Clear

Osteogenesis Imperfecta (SERPINH1, Dachshund Variant)

Clear

Osteogenesis Imperfecta (COL1A1, Golden Retriever Variant)

Clear

P2Y12 Receptor Platelet Disorder (P2Y12)

Clear

Pachyonychia Congenita (KRT16, Dogue de Bordeaux Variant)

Clear

Persistent Mullerian Duct Syndrome, PMDS (AMHR2)

Clear

Polycystic Kidney Disease, PKD (PKD1)

Clear

Polyneuropathy (NDRG1 Deletion, Greyhound Variant)

Clear

Pompe's Disease (GAA, Finnish and Swedish Lapphund, Lapponian Herder Variant)

Clear

Prekallikrein Deficiency (KLKB1 Exon 8)

Clear

Primary Ciliary Dyskinesia, PCD (CCDC39 Exon 3, Old English Sheepdog Variant)

Clear

Primary Hyperoxaluria (AGXT)

Clear

Primary Lens Luxation (ADAMTS17)

Clear

Primary Open Angle Glaucoma (ADAMTS17 Exon 11, Basset Fauve de Bretagne Variant)

Clear

Primary Open Angle Glaucoma (ADAMTS10 Exon 17, Beagle Variant)

Clear

Primary Open Angle Glaucoma (ADAMTS10 Exon 9, Norwegian Elkhound Variant)

Clear

Health Report

Other Results

Progressive Retinal Atrophy (SAG)

Clear

Progressive Retinal Atrophy, CNGA (CNGA1 Exon 9)

Clear

Progressive Retinal Atrophy, crd1 (PDE6B, American Staffordshire Terrier Variant)

Clear

Progressive Retinal Atrophy, crd2 (IQCB1)

Clear

Progressive Retinal Atrophy, crd4/cord1 (RPGRIP1)

Clear

Progressive Retinal Atrophy, PRA1 (CNGB1)

Clear

Progressive Retinal Atrophy, prcd (PRCD Exon 1)

Clear

Progressive Retinal Atrophy, rcd1 (PDE6B Exon 21, Irish Setter Variant)

Clear

Progressive Retinal Atrophy, rcd3 (PDE6A)

Clear

Protein Losing Nephropathy, PLN (NPHS1)

Clear

Pyruvate Dehydrogenase Deficiency (PDP1, Spaniel Variant)

Clear

Pyruvate Kinase Deficiency (PKLR Exon 5, Basenji Variant)

Clear

Pyruvate Kinase Deficiency (PKLR Exon 7, Beagle Variant)

Clear

Pyruvate Kinase Deficiency (PKLR Exon 10, Terrier Variant)

Clear

Pyruvate Kinase Deficiency (PKLR Exon 7, Labrador Retriever Variant)

Clear

Pyruvate Kinase Deficiency (PKLR Exon 7, Pug Variant)

Clear

Renal Cystadenocarcinoma and Nodular Dermatofibrosis (FLCN Exon 7)

Clear

Severe Combined Immunodeficiency, SCID (PRKDC, Terrier Variant)

Clear

Health Report

Other Results

Severe Combined Immunodeficiency, SCID (RAG1, Wetterhoun Variant)

Clear

Shaking Puppy Syndrome (PLP1, English Springer Spaniel Variant)

Clear

Skeletal Dysplasia 2, SD2 (COL11A2, Labrador Retriever Variant)

Clear

Skin Fragility Syndrome (PKP1, Chesapeake Bay Retriever Variant)

Clear

Spinocerebellar Ataxia with Myokymia and/or Seizures (KCNJ10)

Clear

Thrombopathia (RASGRP1 Exon 5, American Eskimo Dog Variant)

Clear

Thrombopathia (RASGRP1 Exon 5, Basset Hound Variant)

Clear

Thrombopathia (RASGRP1 Exon 8, Landseer Variant)

Clear

Trapped Neutrophil Syndrome, TNS (VPS13B)

Clear

Urate Kidney & Bladder Stones (SLC2A9)

Clear

Von Willebrand Disease Type II, Type II vWD (VWF Exon 28)

Clear

Von Willebrand Disease Type III, Type III vWD (VWF Exon 4, Terrier Variant)

Clear

Von Willebrand Disease Type III, Type III vWD (VWF Exon 7, Shetland Sheepdog Variant)

Clear

X-Linked Hereditary Nephropathy, XLHN (COL4A5 Exon 35, Samoyed Variant 2)

Clear

X-Linked Myotubular Myopathy (MTM1, Labrador Retriever Variant)

Clear

X-linked Severe Combined Immunodeficiency, X-SCID (IL2RG Exon 1, Basset Hound Variant)

Clear

X-linked Severe Combined Immunodeficiency, X-SCID (IL2RG, Corgi Variant)

Clear

Health Report

Increased risk result

Dilated Cardiomyopathy, DCM1

Stormborn's Fierce Tempest inherited one copy of the variant we tested for Dilated Cardiomyopathy, DCM1

Tempest is at increased risk for DCM1

How to interpret this result

Tempest has one copy of a variant in the PDK4 gene associated with increased risk for DCM in the American Doberman Pinscher. This variant, also referred to as DCM1, is inherited in a dominant manner, meaning having one or two copies of this variant is thought to confer the same amount of risk. However, the variant is thought to have incomplete penetrance: That is, not all dogs with this variant will ultimately show signs of DCM. Moreover, the impact of this variant in other breeds of dog besides the Doberman has yet to be fully understood. However, if your veterinarian thinks Tempest shows signs of having DCM based on their diagnostic testing, you now have the opportunity to discuss early treatment. Please consult with your veterinarian regarding a diagnostic and treatment plan for Tempest.

What is Dilated Cardiomyopathy, DCM1?

DCM is the most common acquired heart disease of adult dogs. The heart has two heavily muscled ventricles that pump blood away from the heart. This disease causes progressive weakening of the ventricles by reducing the muscle mass, which causes the ventricles to dilate. Dilated ventricles do not contract and circulate oxygenated blood well, which eventually leads to heart failure.

When signs & symptoms develop in affected dogs

This disease can rarely be seen in puppies and young adults. It is typically seen in middle aged to older dogs.

Signs & symptoms

In the early stages of DCM, you will likely not notice any changes in your dog. DCM typically presents at the end stages of the disease, when the heart is failing. Signs include weakness, cold toes and ears, blue-grey gums and tongue, and respiratory distress. If you see these signs, take your dog immediately to an emergency veterinarian!

How vets diagnose this condition

The earlier a diagnosis can be reached, the better the outcome. If you are concerned about your dog’s heart, discuss it with your veterinarian who can run basic preliminary tests. They may recommend a visit to a veterinary cardiologist for a complete evaluation, including an ultrasound of the heart (echocardiogram).

How this condition is treated

Treatment is completely dependent on how advanced the disease is at the time of diagnosis. It can range from monitoring the patient periodically to intensive hospitalization at specialty veterinary practices.

Actions to take if your dog is affected

The cause of this disease is multifactorial and not completely understood. Genetics, nutrition, infections and environmental exposures can all play a role in the development of DCM. In fact, DCM has recently been featured extensively in the news due to suspected nutritional deficiencies in some grain free diets.
Annual echocardiograms by a board certified cardiologist and annual Holter monitoring are the best ways to diagnose DCM early.

Health Report

Increased risk result

Dilated Cardiomyopathy, DCM2

Stormborn's Fierce Tempest inherited one copy of the variant we tested for Dilated Cardiomyopathy, DCM2

Tempest is at increased risk for DCM2

How to interpret this result

Tempest has one copy of a variant in the TTN gene associated with increased risk for DCM in the American Doberman Pinscher. This variant, also referred to as DCM2, is inherited in a dominant manner, meaning having one or two copies of this variant is thought to confer the same amount of risk. However, the variant is thought to have incomplete penetrance: That is, not all dogs with this variant will ultimately show signs of DCM. Moreover, the impact of this variant in other breeds of dog besides the Doberman has yet to be fully understood. However, if your veterinarian thinks Tempest shows signs of having DCM based on their diagnostic testing, you now have the opportunity to discuss early treatment. Please consult with your veterinarian regarding a diagnostic and treatment plan for Tempest.

What is Dilated Cardiomyopathy, DCM2?

When signs & symptoms develop in affected dogs

This disease can rarely be seen in puppies and young adults. It is typically seen in middle aged to older dogs.

Signs & symptoms

How vets diagnose this condition

How this condition is treated

Actions to take if your dog is affected

The cause of this disease is multifactorial and not completely understood. Genetics, nutrition, infections and environmental exposures can all play a role in the development of DCM. In fact, DCM has recently been featured extensively in the news due to suspected nutritional deficiencies in some grain free diets.
Annual echocardiograms by a board certified cardiologist and annual Holter monitoring are the best ways to diagnose DCM early.

Health Report

Notable result

ALT Activity

Stormborn's Fierce Tempest inherited one copy of the variant we tested for Alanine Aminotransferase Activity

Why is this important to your vet?

Tempest has one copy of a variant associated with reduced ALT activity as measured on veterinary blood chemistry panels. Please inform your veterinarian that Tempest has this genotype, as ALT is often used as an indicator of liver health and Tempest is likely to have a lower than average resting ALT activity. As such, an increase in Tempest’s ALT activity could be evidence of liver damage, even if it is within normal limits by standard ALT reference ranges.

What is Alanine Aminotransferase Activity?

Alanine aminotransferase (ALT) is a clinical tool that can be used by veterinarians to better monitor liver health. This result is not associated with liver disease. ALT is one of several values veterinarians measure on routine blood work to evaluate the liver. It is a naturally occurring enzyme located in liver cells that helps break down protein. When the liver is damaged or inflamed, ALT is released into the bloodstream.

How vets diagnose this condition

Genetic testing is the only way to provide your veterinarian with this clinical tool.

How this condition is treated

Veterinarians may recommend blood work to establish a baseline ALT value for healthy dogs with one or two copies of this variant.

Genetic Diversity and Inbreeding

Coefficient of Inbreeding (COI)

Genetic Result:: 36%

Our genetic COI measures the proportion of your dog’s genome (her genes) where the genes on the mother’s side are identical by descent to those on the father’s side. The higher your dog’s coefficient of inbreeding (the percentage), the more inbred your dog is.

Your Dog’s COI

This graph represents where your dog’s inbreeding levels fall on a scale compared to both dogs with a similar breed makeup to her (the blue bars) and all purebred dogs (the grey line).

Genetic Diversity and Inbreeding

More on the Science

Embark scientists, along with our research partners at Cornell University, have shown the impact of inbreeding on longevity and fertility and developed a state-of-the-art, peer-reviewed method for accurately measuring COI and predicting average COI in litters.

Citations

About Embark

Embark Veterinary is a canine genetics company offering research-grade genetic tests to pet owners and breeders. Every Embark test examines thousands of genetic markers, and provides results for over NaN genetic health conditions, breed identification, clinical tools, and more.

Embark is a research partner of the Cornell University College of Veterinary Medicine and collaborates with scientists and registries to accelerate genetic research in canine health. We make it easy for customers and vets to understand, share and make use of their dog’s unique genetic profile to improve canine health and happiness.

Learn more at embarkvet.com

Veterinarians and hospitals can send inquiries to veterinarians@embarkvet.com.